Board of Directors
Jonathan Ross Goodman, LL.B., M.B.A.
Jonathan Goodman is the founder, President & CEO of Paladin Labs Inc., a Toronto Stock Exchange listed, specialty pharmaceutical company with a market capitalization in excess of $300 million dollars. Prior to founding Paladin, Mr. Goodman was the Vice President of Business Development at Pharmascience Inc., where he led Pharmascience’s successful efforts to in-license new products and develop key corporate alliances with such companies as Eli Lilly, Schering, Novartis, Berlex, Alcon and Fournier. In addition, Mr. Goodman was a consultant with Bain & Company, a management consulting firm, and also worked in brand management for Procter & Gamble. Mr. Goodman is a recipient of the Globe and Mail’s Top 40 Under 40 Award and was named Quebec Entrepreneur of the Year in the Life Sciences by the National Post and Ernst & Young. Mr. Goodman is a member of the Board of Directors of the Canadian Chamber of Commerce, Medicago Inc., and NeurAxon Inc. Mr. Goodman holds a B.A. with Great Distinction from McGill University and the London School of Economics with 1st Class Honours. Additionally, Mr. Goodman holds an LL.B. and M.B.A. from McGill. Mr. Goodman is a member of the Bars of New York and Massachusetts, is an Accredited Pharmaceutical Manufacturing Representative, is a sessional lecturer in entrepreneurship at McGill University and is a part-time faculty member of Concordia University.
Jonathan Goodman is the Chairman of the Board and serves on the Audit Committee.